Along with TREM2, these cells were enriched for genes involved in lipid metabolism (APOE), immunosuppression (MARCO, CD163, CD81), and the complement cascade (C1QB), suggesting that TREM2 specifically marks a subset of tumor-specific immunosuppressive macrophages [56]. The gene discussed is TREM2; the disease is neoplasm.